PIK3CA and breast cancer: Our main findings contradict the results of another large meta-analysis by Fillbrunn et al. which was performed on more homogeneous samples than that of Sobhani et al. and which also revealed a negative prognostic and predictive effect of PIK3CA mutation in advanced HR+/HER2− breast cancer [23].